Kiaora Pharmaceuticals Private Limited
About Kiaora Pharmaceuticals Private Limited
Data last updated:
Kiaora Pharmaceuticals Private Limited is a private limited company based in Jalandhar, Punjab, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 20 December 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U00304PB2005PTC029388. Its GSTIN is 03AADCK0370P1ZJ (Punjab).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1.3 Lakh. It is led by directors including Shivam Mittal and Leena Mittal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 650 – R Model Town Jalandhar City., Punjab, India.
As per the financials filed for FY 2025, the company reported a revenue of ₹63.35 Lakh, a decline of 22% compared to the previous year. For the same year it recorded a net loss of ₹5.39 Lakh (net margin -8.5%) and EBITDA of -₹2.57 Lakh (EBITDA margin -4.1%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 1% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Kiaora Pharmaceuticals Private Limited's registered office is in Jalandhar, Punjab. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address650 – R Model Town Jalandhar City., Punjab, India
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Kiaora Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Kiaora Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Kiaora Pharmaceuticals Private Limited, buy the company report.
Financials of Kiaora Pharmaceuticals Private Limited
FY 2025 filings availableKiaora Pharmaceuticals Private Limited reported revenue of ₹63.35 Lakh (down 22% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 22% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 1%. EBITDA fell 134% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹2.57 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹5.39 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -4.1% | ||||
| Net Profit Margin | -8.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Kiaora Pharmaceuticals Private Limited, buy the company report.
Board of directors of Kiaora Pharmaceuticals Private Limited
Kiaora Pharmaceuticals has 3 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shivam Mittal | Director | 09 Mar 2021 | 5 Years 8 Months | Current |
| Leena Mittal | Director | 10 May 2016 | 10 Years 6 Months | Current |
| Pradumn Kumar Mittal | Director | 31 May 2016 | 10 Years 5 Months | Current |
Peer comparison
Kiaora Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Welbeck Pharmaceuticals Private Limited | ₹63.48 Lakh (FY 2025) | -20.0% | New Delhi, Delhi, India | |||
| LMGG Pharmaceuticals Private Limited | ₹63.45 Lakh (FY 2025) | 147.0% | Jaipur, Rajasthan, India | |||
| Driven Pharmaceuticals Private Limited | ₹63.45 Lakh (FY 2024) | 48.0% | Lucknow, Uttar Pradesh, India | |||
| Kiaora Pharmaceuticals Private Limitedthis company | ₹63.35 Lakh (FY 2025) | -₹5.39 Lakh | -8.5% | -22.0% | Jalandhar, Punjab, India | |
| Genderma Pharmaceuticals Private Limited | ₹63.13 Lakh (FY 2025) | -26.0% | Uttar Pradesh, India | |||
| Susruta Pharmaceuticals Private Limited | ₹63.09 Lakh (FY 2022) | -26.0% | Kolkata, West Bengal, India |
To see the full peer comparison of Kiaora Pharmaceuticals Private Limited, buy the company report.
Auditor
Kiaora Pharmaceuticals Private Limited is audited by RAJESH MADAN GUPTA & CO. for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAJESH MADAN GUPTA & CO. | FY 2017 | 008000N |
Shareholding
The shareholding of Kiaora Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Kiaora Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Kiaora Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Kiaora Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Kiaora Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 03AADCK0370P1ZJ | Punjab | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Kiaora Pharmaceuticals Private Limited, buy the company report.
Recent activity
Kiaora Pharmaceuticals Private Limited has 9 board changes on record since 2016: 3 appointments and 6 cessations. The latest: Shivam Mittal ceased to be Additional Director on 30 Nov 2021.
Frequently asked questions
Kiaora Pharmaceuticals is an active private limited company based in Jalandhar, Punjab, India. The company works in other wholesale, within the trading industry. It was incorporated on 20 December 2005 (21+ years old) and is registered under CIN U00304PB2005PTC029388.
Kiaora Pharmaceuticals has 3 current directors:
- Shivam Mittal - Director
- Leena Mittal - Director
- Pradumn Kumar Mittal - Director
The latest financial statements of Kiaora Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Kiaora Pharmaceuticals is 03AADCK0370P1ZJ, registered in Punjab.
The CIN (Corporate Identification Number) of Kiaora Pharmaceuticals is U00304PB2005PTC029388. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Kiaora Pharmaceuticals was incorporated on 20 December 2005, making it 21+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Kiaora Pharmaceuticals by revenue are Welbeck Pharmaceuticals Private Limited, LMGG Pharmaceuticals Private Limited, Driven Pharmaceuticals Private Limited, Genderma Pharmaceuticals Private Limited, Susruta Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Shivam Mittal ceased to be Additional Director on 30 Nov 2021. Shivam Mittal was appointed as Director on 09 Mar 2021. Nishant Mittal ceased to be Managing Director on 22 Feb 2021. Kiaora Pharmaceuticals has 9 board changes on record in total.
The registered office of Kiaora Pharmaceuticals is at 650 – R Model Town Jalandhar City., Punjab, India.
Kiaora Pharmaceuticals operates in the trading industry, in the other wholesale segment.
The compliance status of Kiaora Pharmaceuticals is compliant as of 19 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
